Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …
BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2024 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …
Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
Delayed drug T-cell immune-mediated hypersensitivity reactions have a large clinical
heterogeneity varying from mild maculopapular exanthema (MPE) to severe cutaneous …
heterogeneity varying from mild maculopapular exanthema (MPE) to severe cutaneous …
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions
A Gibson, P Deshpande, CN Campbell… - Journal of Allergy and …, 2023 - Elsevier
Severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome, toxic
epidermal necrolysis (SJS/TEN), and drug reaction with eosinophilia and systemic …
epidermal necrolysis (SJS/TEN), and drug reaction with eosinophilia and systemic …
First-Line Antituberculosis Drug Challenge Reactions in Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in an HIV Endemic Setting
Background In high HIV prevalence settings, first-line antituberculosis drug (FLTD)-
associated drug reaction with eosinophilia and systemic symptoms (DRESS) poses …
associated drug reaction with eosinophilia and systemic symptoms (DRESS) poses …
Durability of immune responses after drug reaction with eosinophilia and systemic symptoms
A Awad, E Mouhtouris, A Clatch, F James… - The Journal of Allergy …, 2024 - Elsevier
Durability of immune responses after drug reaction with eosinophilia and systemic symptoms
Page 1 Journal Pre-proof Durability of immune responses after drug reaction with eosinophilia …
Page 1 Journal Pre-proof Durability of immune responses after drug reaction with eosinophilia …
Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients
T Chimbetete, P Choshi, S Pedretti, M Porter… - Frontiers in …, 2023 - frontiersin.org
Introduction Drug Reaction with Eosinophilia Systemic Symptoms (DRESS) is more common
in persons living with HIV (PLHIV), and first-line anti-TB drugs (FLTDs) and cotrimoxazole …
in persons living with HIV (PLHIV), and first-line anti-TB drugs (FLTDs) and cotrimoxazole …
The immunopathogenic mechanism of severe cutaneous adverse reactions to first line anti-tuberculosis drugs
P Choshi - 2024 - open.uct.ac.za
Background and hypothesis In HIV-TB endemic settings like South Africa, first line anti-
tuberculosis drugs (FLTD) are the commonest cause of severe immune mediated adverse …
tuberculosis drugs (FLTD) are the commonest cause of severe immune mediated adverse …
Time to reinvent the wheel for drug causality diagnostic approaches to severe cutaneous adverse reactions.
A Awad, JA Trubiano - Australasian Journal of Dermatology, 2023 - search.ebscohost.com
Keywords: ex vivo assays; in vivo testing; severe cutaneous adverse reactions EN ex vivo
assays in vivo testing severe cutaneous adverse reactions e79 e81 3 02/17/23 20230201 …
assays in vivo testing severe cutaneous adverse reactions e79 e81 3 02/17/23 20230201 …